Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study)

NCT01637558 is registered in ClinicalTrials.gov with University of Cape Town as lead sponsor.

NCT NCT01637558
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01637558 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study)
Lead sponsor
University of Cape Town
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2012
Completion date
July 31, 2017
Enrollment
200 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, tuberculosis